MedPath

Laser Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

FDA:10

Drug Approvals

Hyoscyamine Sulfate

Approval Date
Jan 29, 2024
FDA

Urea Cream 41%

Approval Date
Oct 11, 2023
FDA

Urea Cream 40%

Approval Date
Oct 11, 2023
FDA

Sodium Sulfacetamide

Approval Date
Sep 14, 2023
FDA

Phenobarbital

Approval Date
Aug 7, 2023
FDA

Selenium Sulfide

Approval Date
Sep 13, 2022
FDA

Selenium Sulfide

Approval Date
Sep 13, 2022
FDA

Sodium Sulfacetamide

Approval Date
Aug 11, 2022
FDA

Hemmorex-HC

Approval Date
Aug 5, 2021
FDA

Hemmorex-HC

Approval Date
Jul 16, 2021
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.